SCHEMBL27362909

SCHEMBL27362909

C[C@H]1C=C(Cl)C=CC1(C)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3248406 0.76
SCHEMBL29519922 0.76
SCHEMBL31255845 0.74
Potassium SCHEMBL31255853 0.74
Lithium SCHEMBL31255852 0.74
Ammonia Solution, Strong SCHEMBL31255848 0.74
SCHEMBL31255840 0.74
Calcium SCHEMBL31255831 0.72
SCHEMBL27705724 0.68
SCHEMBL2143005 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024015055-A1 PYRAZOLO[3,4-D]PYRIMIDIN-6-YL-SULFONAMIDE DERIVATIVES FOR THE INHIBITION OF SGK-1 AND TREATMENT OF CANCER THRYV THERAPEUTICS INC. (CA) 2024-01-18 WO disclosed